The ICGEB research groups participate in many calls for proposals on topics relevant to their fields of interest and are supported by a vast array of donors: from Governmental bodies to private companies, and charities. The major ongoing projects are shown here, divided under the Sustainable Development Goals that ICGEB strives to address.
zero hunger
SUSGRAPE promotiong sustainable viticulture through ICT within ITA-SLO cross-border areas
Donor:
Regione Autonoma Friuli Venezia Giulia
Partners:
INTERREG Italia – Slovenia 2014-2020
ICGEB Bacteriology Lab
Duration: 2017-2020
Genetic improvement of rice for yield NUE, WUE, abiotic and biotic stress tolerance through RNA guided genome editing (CRISPR-Cas9/Cpf1)
Donor:
Indian Council of Agriculture Research (ICAR)
ICGEB Crop Improvement lab
Duration: 2017-2020
Re-designing Rice Crops for improvement grain micronutrient quality using CRISPR-Cas9/Cfp1 genome editing
Donor:
Indian Council of Agriculture Research (ICAR)
ICGEB Nutritional Improvement of Crops lab
Duration: 2017-2020
good health
Cardiomiciti di cellule staminali per una cardiologia personalizzata – CardioStem
Donor
Regione Autonoma Friuli Venezia Giulia (L.R. 17/2014)
Partners
Azienda Sanitaria Universitaria Integrata Trieste ASUITS (Struttura complessa di Cardiologia)
ICGEB Molecular Medicine lab
Duration: 2019-2021
Bisimilars: Contribution to setting up the laboratory dedicated to research and quality certification of processes and biosimilar pharmaceuticals
Donor
Regione Autonoma Friuli Venezia Giulia (L.R. 17/2014)
ICGEB Biotechnology Development Unit
Duration: 2017-2020
TRAIN Big data and models of diseases: cross border platform of validated kits for biotech industry
Donor
Regione Autonoma Friuli Venezia Giulia
Partners
INTERREG Italia – Slovenia 2014-2020
ICGEB Biotechnology Development Unit
Duration: 2017-2020
Donor
Regione Autonoma Friuli Venezia Giulia
Partners
INTERREG Italia – Slovenia 2014-2020, Valdoltra Orthopedic Hospital (Ankaran, Slovenia), University of Ljubljiana, Faculty of Chemistry and Chemical Technology, Dr. Paladin, Jafral
ICGEB Molecular Virology Lab
Duration: 2019-2021
Does lung tumour development suppress the presentation of neo-epitopes by type 1 denditric cells?
Donor
AIRC
ICGEB Cellular Immunology Lab, Trieste
Duration: 2018-2022
Charachterisation of the functions of the Human Papillomavirus E6 and E7 oncoproteins
Donor
AIRC
Partners
AIRC investigator Grant 2019
ICGEB Tumour Virology Lab
Duration: 20179-2024
Progetto per il consolidamento di una piattaform a di Medicina di Precisione in Cardiologia
Donor
Fondazione CRTrieste CARDIOGEN
Partners
Azienda Sanitaria Universitaria Integrata Trieste ASUITS (Struttura complessa di Cardiologia)
ICGEB Molecular Medicine Lab
Duration: 2017-2022
Development of exon specific U1 snRNA-based therapy for familiar Dysautonomia
Donor
Fondazione Telethon
ICGEB Human Molecular Genetics Lab
Duration: 2018-2021
MicroRNA per la terapia della fibrosi polmonare idiopatica
Donor:
Fondazione CRTrieste
Partners
University of Trieste
ICGEB Cardiovascular Biology Lab
Duration: 2017-2020
Full length RGNEF and/or“RGNEF leucine –rich domani”as a therapeutic target in ALS
Donor
Western Ontario University
ICGEB Molecular Pathology Lab
Duration: 2019-2022
Programming the failing heart to a regenerative state
Donor:
Foundation Leducq
Partners
Univ. Washington, Hubrecht Institute, Univ. Med. Centre Goettingen, Univ. Texas
ICGEB Molecular Medcine Lab
Duration: 2016-2020
Pre-clinical validation of FDA approved molecules able to rescue GAA pre-mRNAs plicing of c.-32-13T>G mutants as therapeutic agents for late- onset Pompe Disease
Donor:
Acid Maltase Deficiency Association – AMDA
Partners
Azienda Sanitaria Universitaria Integrata di Udine ASUIUD (University Hospital “Santa Maria della Misericordia”)
ICGEB Molecular Pathology Lab
Duration: 2019-2022
Point-of-care per la rivelazione simultanea dei virus Zika, Dengue e Chikungunya
Donor
Regione Autonoma Friuli Venezia Giulia
Partners
Alifax Research, Laboratori Riuniti
ICGEB Molecular Virology Lab
Duration: 2018-2020
Epigenetic cross-talks and novel therapeutic strategies to prevent disease progression in ERG fusion positive prostate cancer
Donor
National Research Foundation – South Africa/SWISS Joint Research Cooperation Programme
Partners
Univ. Bern, Inst. Oncology Research, Bellinzona
ICGEB Cancer Genomics Lab
Duration: 2017-2020
Regulation of host splicing machinery by factors from mycobacterium tuberculosis and its impact on host innate defense mechanism
Donor
Wellcome Trust Alliance
ICGEB Cellular Immunology Lab
Duration: 2018-2022
A novel exon-specific U1 snRNA strategy to correct splicing in Familial Dysautonomia
Donor
National Eye Institute of the National Institutes of Health
Partner: Massachusetts General Hospital
ICGEB Human Molecular genetics Lab
Duration: 2018-2022
Biomolecular characterisation of Malaria parasite drug target dihydropteroate synthase
Donor
Department of Science and Technology (DST)
ICGEB Structural Parasitology Lab
Duration: 2018-2021
A Phase I, clinical trial to assess the safety and immunogenicity of P. falciparum vaccines
Donor: Biotechnology Industry Research Assistance Council (BIRAC)
ICGEB xx xx Lab
Duration: 2018-2020
Evolution and transmission of drug resistant tuberculosis in Agartala, Kohima and Imphal population
Donor: Department of Biotechnology (DBT)
Partner: Manipur Univ., Jawaharlal Nehru Inst. Medical Sciences, Naga Hospital Authority, Agartala Gov. Med. College
ICGEB Translational Health Lab
Duration: 2018-2021
Title: Translational research and clinical development of malaria vaccine candidates
Donor: Department of Biotechnology (DBT)
ICGEB xx Chauhan Lab
Duration: 2019-2022
Synthetic biology approach for producing artemisinin in edible plant and effective Malaria treatment by oral delivery of plant cells
Donor
Department of Biotechnology (DBT)
ICGEB Metabolic Engineering Lab
Duration: 2018-2021
Functional delineation of viral encoded RNAi suppressor on plant miRNA pathways
Donor
Department of Biotechnology (DBT)
ICGEB Transcriptional Regulation Lab
Duration: 2018-2021
Genomics-driven dissection of susceptibility geographical focus on NER
Donor
Department of Biotechnology (DBT)
Partner:
National Inst. Biomed. Genomics, Foundation Neglected Disease Res., Mizoram University, Dpt. Health & Family Welfare
ICGEB Cellular Immunology Lab
Duration: 2018-2021
Development of a chikungunya candidate vaccine in vesicular stomatitis virus (VSV) gene delivery platform
Donor
Department of Biotechnology (DBT)
ICGEB Vector Borne Diseases Lab
Duration: 2019-2022
Comprehensive omics studies to understand the biology of drug resistant Mycobacterium tuberculosis clinical isolates from Arunachal Pradesh
Donor
Department of Biotechnology (DBT)
ICGEB Parasitic Cell Biology Lab
Duration: 2019-2022
Human B Cell responses and receptor repertoire in dengue patients from India
Donor
Department of Biotechnology (DBT)
ICGEB EMORY-ICGEB Vaccine Program
Duration: 2019-2021
Hit to lead development of potent anti-parasitic natural product scaffolds
Donor
Department of Science and Technology (DST)
ICGEB Structural Parasitology Lab
Duration: 2019-2023
Membrane biogenesis in Apicomplexa parasites: trafficking and recycling lipid sources for membrane remodelling as drug targets against malaria and toxoplasmosis
Donor
Indo-French Centre for Promotion of Advanced Research
ICGEB Parasite Cell Lab
Duration: 2019-2023
Translational Research Consortia for establishing platform technologies to support prophylactic and therapeutic strategies for Dengue discovey to proof of concept
Donor
Biotechnology Industry Research Assistance Council (BIRAC)
ICGEB EMORY-ICGEB Vaccine Program
Duration: 2019-2023
Translational research consortia TRC for Chikungunya virus
Donor
Biotechnology Industry Research Assistance Council (BIRAC)
ICGEB Vectorn Borne Diseases Lab
Duration: 2019-2024
Structure determination and targeting of ubiquitously expressed membrane integrated form of chloride intracellular channels (CLICs) for discovery of small molecular anti-cancer therapeutics
Donor
Department of Biotechnology (DBT)
ICGEB Membrane Protein Biology Lab
Duration: 2019-2023
Targeting drug resistance in tuberculosis and malaria
Donor
Department of Biotechnology (DBT)
ICGEB Structural Immunology Lab
Duration: 2019-2023
Effect of Repeated Chemotherapy with Praziquantel on resistance to reinfection and protection against pathology during murine schistosomiasis: Mechanistic studies
Donor
MERCK Global Health Institute
ICGEB Cytokines & Disease Lab
Duration: 2017-2020
Bio molecular characterization of a malaria parasite drug substrate dihydropteroate synthase (DHPS)
Donor
Department of Science and Technology (DST)
ICGEB Structural Parasitology Lab
Duration: 2019-2023
quality education
ComUnicaRe per crescere In SAlute-Curiosa
Donor
Regione Autonoma Friuli Venezia Giulia
ICGEB Cardiovascular Biology Lab
Duration: 2019-2022
affordable energy
Development of paenibacillus polymyxa as a platform for production of branched chain alcohols
Donor
Department of Biotechnology (DBT)
ICGEB Microbial EngineeringI Lab
Duration: 2019-2022
Chloroplast metabolic engineering of Artemisia annua for enhancing artemisinin biosynthesis
Donor
Department of Biotechnology (DBT)
ICGEB Microbial Engineering Lab
Duration: 2018-2021
Reducing industrial waste from sugar cane processing in India
Donor
Department of Biotechnology (DBT)
ICGEB MicrobialEngineering Lab
Duration: 2018-2021
Demonstration of algal chassis for the photo autotrophic production of isoprenoids
Donor
Department of Biotechnology (DBT)
ICGEB Omics of Algae Lab
Duration: 2018-2021
Indian Marine cyanobacterial host for production of drop-in fuels
Donor
Department of Biotechnology (DBT)
ICGEB Microbial Engineering Lab
Duration: 2019-2022
Carbonaceous gas to fuel by genetically engineered organisms
Donor
TATA STEEL LIMITED
ICGEB Microbial Engineering Lab
Duration: 2019-2022
industry innovation
partnership for the goals
